These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Gaucher's disease initially diagnosed as depression. Clemons J; Jasser MZ; Noble G; Monahan BP Am J Psychiatry; 1997 Feb; 154(2):290. PubMed ID: 9016289 [No Abstract] [Full Text] [Related]
46. [Current treatment for Gaucher's disease and new prospects]. Giraldo P; Latre P Med Clin (Barc); 2011 Sep; 137 Suppl 1():50-4. PubMed ID: 22230127 [TBL] [Abstract][Full Text] [Related]
47. [Idiopathic macular preretinal membrane in the elderly]. Zhang HR Zhonghua Yan Ke Za Zhi; 1990 Sep; 26(5):275-8. PubMed ID: 2086137 [TBL] [Abstract][Full Text] [Related]
48. [Eye changes in Gaucher's disease]. Stark H Klin Monbl Augenheilkd; 1983 Sep; 183(3):216-20. PubMed ID: 6645266 [TBL] [Abstract][Full Text] [Related]
49. Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase. Mistry PK; Davies S; Corfield A; Dixon AK; Cox TM Q J Med; 1992 Jul; 83(303):541-6. PubMed ID: 1484931 [TBL] [Abstract][Full Text] [Related]
50. Case report: serendipitous Gaucher's disease presenting as elevated erythrocyte sedimentation rate due to monoclonal gammopathy. Liel Y; Hausmann MJ; Mozes M Am J Med Sci; 1991 Jun; 301(6):393-4. PubMed ID: 2039025 [TBL] [Abstract][Full Text] [Related]
51. Non-specific symptomatogy presenting in a patient with Gaucher's disease creating a challenging diagnosis: a case report. Ysla F; Llorens C; Figueroa J; Bolaños G; Velázquez R; Belmonte E Bol Asoc Med P R; 2012; 104(4):50-3. PubMed ID: 23763225 [TBL] [Abstract][Full Text] [Related]
53. Splenic abscess in a patient with type 3 Gaucher's disease receiving enzyme replacement therapy. Maclean K; Wilson MJ J Pediatr; 1999 Feb; 134(2):245-7. PubMed ID: 9931539 [TBL] [Abstract][Full Text] [Related]
54. Cardiac response to enzyme-replacement therapy in Gaucher's disease. Spada M; Chiappa E; Ponzone A N Engl J Med; 1998 Oct; 339(16):1165-6. PubMed ID: 9776652 [No Abstract] [Full Text] [Related]
55. Macular Telangiectasia Type 2 Without Clinically Detectable Vasculopathy. Gillies MC; Mehta H; Bird AC JAMA Ophthalmol; 2015 Aug; 133(8):951-4. PubMed ID: 26067680 [TBL] [Abstract][Full Text] [Related]
56. Miglustat: new drug. In type 1 Gaucher's disease : a slight benefit after imiglucerase therapy. Prescrire Int; 2005 Oct; 14(79):168-70. PubMed ID: 16285070 [TBL] [Abstract][Full Text] [Related]
57. [Uveitis masquerade syndrome in Gaucher disease. Causal treatment by alglucerase substitution therapy]. Dann K; Althaus C; Kersten A; vom Dahl S; Sundmacher R Klin Monbl Augenheilkd; 1998 Dec; 213(6):358-61. PubMed ID: 10048015 [TBL] [Abstract][Full Text] [Related]
58. [Enzyme therapy in children with severe forms of Gaucher's disease]. Zeman J; Hrebícek M; Vepreková L; Kytnarová J; Houstková H; Malinová V; Hodanová K; Poupĕtová H; Ledvinová J; Hoza J Cas Lek Cesk; 1997 Feb; 136(3):95-7. PubMed ID: 9221177 [TBL] [Abstract][Full Text] [Related]
59. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Charbel Issa P; Holz FG; Scholl HP Ophthalmology; 2007 Sep; 114(9):1736-42. PubMed ID: 17822979 [TBL] [Abstract][Full Text] [Related]
60. [The ocular fundus findings in dengue fever]. Wen KH; Sheu MM; Chung CB; Wang HZ; Chen CW Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Jan; 5(1):24-30. PubMed ID: 2733064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]